Deals & Capital Markets
GSK Bets $2.2 Billion on Food Allergy Breakthrough in First Major Deal Under New CEO
19h ago
You're signed outSign in or to get full access.
G
GSK (GSK)·Earnings Reports
No Earnings Reports Available
Earnings reports will appear here once they become available.
Research analysts covering GSK.